Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-25-019267
Filing Date
2025-02-03
Accepted
2025-02-03 16:07:15
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 d919606ds3.htm S-3 478969
2 EX-1.2 d919606dex12.htm EX-1.2 225854
3 EX-4.6 d919606dex46.htm EX-4.6 308257
4 EX-4.8 d919606dex48.htm EX-4.8 95269
5 EX-4.9 d919606dex49.htm EX-4.9 97480
6 EX-4.10 d919606dex410.htm EX-4.10 85247
7 EX-5.1 d919606dex51.htm EX-5.1 28664
8 EX-23.1 d919606dex231.htm EX-23.1 1534
9 EX-FILING FEES d919606dexfilingfees.htm EX-FILING FEES 50636
10 GRAPHIC g919606g0131093123601.jpg GRAPHIC 2409
11 GRAPHIC g919606g04k04.jpg GRAPHIC 42492
12 GRAPHIC g919606g88o49.jpg GRAPHIC 267186
  Complete submission text file 0001193125-25-019267.txt   1803138
Mailing Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041
Business Address 650 CASTRO STREET, SUITE 450 MOUNTAIN VIEW CA 94041 773-255-5012
Alto Neuroscience, Inc. (Filer) CIK: 0001999480 (see all company filings)

EIN.: 834210124 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-284667 | Film No.: 25582529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)